Table 4. Univariate and multivariate analysis to identify independent risk factors for LRE development.
Variables | Univariate | Multivariate | ||
(at 3 months after Kasai) | P | P | Hazard ratio | 95% confidence interval |
LSM value (kPa) | <0.001 | 0.018 | 1.258 | 1.032–1.522 |
AST (IU/L) | 0.001 | 0.369 | 1.006 | |
ALT (IU/L) | 0.039 | 0.323 | 0.992 | |
Albumin (g/dL) | <0.001 | 0.538 | 0.529 | |
Total bilirubin (mg/dL) | <0.001 | 0.054 | 1.635 | |
Direct bilirubin (mg/dL) | <0.001 | |||
ALP (IU/L) | 0.063 | |||
Platelet count(109/L) | 0.139 |
LRE, liver related events; LSM, liver stiffness measurement; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT, gamma glutamyl transpeptidase; ALP, alkaline phosphatase.